Astrana Health Inc ASTH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Foothill Regional Medical Center Recognized Among Healthgrades' 2027 America's 100 Best Hospitals for Orthopedic Surgery and Joint Replacement
Astrana Health, Inc. Reports Third Quarter 2026 Results
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
Trading Information
- Previous Close Price
- $32.94
- Day Range
- $31.25–33.02
- 52-Week Range
- $18.08–51.60
- Bid/Ask
- $28.50 / $50.51
- Shares Outstanding
- 49.67M
- Market Cap
- $1.58B
- Volume/Avg
- 334,731 / 380,604
Key Statistics
- Price/Earnings (Normalized)
- 14.83
- Price/Sales
- 0.40
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.98%
Company Profile
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company’s three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,000
Valuation
Metric | ASTH |
|---|---|
Price/Earnings (Normalized) | 14.83 |
Price/Book Value | 1.83 |
Price/Sales | 0.40 |
Price/Cash Flow | 9.14 |
Price/Earnings
ASTH
Financial Strength
Metric | ASTH |
|---|---|
Quick Ratio | 1.21 |
Current Ratio | 1.25 |
Interest Coverage | 2.06 |
Quick Ratio
ASTH
Profitability
Metric | ASTH |
|---|---|
Return on Assets (Normalized) | 6.04% |
Return on Equity (Normalized) | 17.10% |
Return on Invested Capital (Normalized) | 10.47% |
Return on Assets
ASTH
Medical Care Facilities Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| HCA Healthcare Inc HCA | LOCK|<J^C>wC | LOCK|Vn>Zc | $105B | |||
| Fresenius SE & Co KGaA Registered Shares FSNUF | — | LOCK|Y%d% | $33B | |||
| Fresenius SE & Co KGaA ADR FSNUY | — | LOCK|>HRF? | $33B | |||
| Tenet Healthcare Corp THC | LOCK|>NZC^G | LOCK|%$Gz | $23B | |||
| Encompass Health Corp EHC | — | LOCK|!>?V | $14B | |||
| Fresenius Medical Care AG FMCQF | — | LOCK|R%g# | $11B | |||
| Fresenius Medical Care AG ADR FMS | LOCK|W<k&?K? | LOCK|y@&Q# | $11B | |||
| Universal Health Services Inc Class B UHS | LOCK|@#^%G^ | LOCK|dv!V | $11B | |||
| DaVita Inc DVA | LOCK|ry^@Fn | LOCK|G#lwK | $11B | |||
| Ensign Group Inc ENSG | — | LOCK|%vZW | $11B |
United States